Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2008-3-3
pubmed:abstractText
Positron emission tomography using 18F-fluorodeoxyglucose (FDG-PET) has been successfully evaluated in the management of non-Hodgkin's lymphoma (NHL).1-3 Histological transformation (HT) of indolent lymphoma is a dramatic event that occurs in 5-10% of the patients and carries a dismal prognosis.4,5 Previous studies prove that indolent lymphoma entities show a lower FDG uptake when compared with aggressive lymphomas.6-8 We therefore postulated that FDG-PET/CT identifies aggressive transformation sites and can guide biopsies.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1592-8721
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
93
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
471-2
pubmed:meshHeading
pubmed-meshheading:18310543-Adult, pubmed-meshheading:18310543-Aged, pubmed-meshheading:18310543-Aged, 80 and over, pubmed-meshheading:18310543-Biopsy, pubmed-meshheading:18310543-Disease Progression, pubmed-meshheading:18310543-Female, pubmed-meshheading:18310543-Fluorine Radioisotopes, pubmed-meshheading:18310543-Fluorodeoxyglucose F18, pubmed-meshheading:18310543-Humans, pubmed-meshheading:18310543-Lymphoma, Non-Hodgkin, pubmed-meshheading:18310543-Male, pubmed-meshheading:18310543-Middle Aged, pubmed-meshheading:18310543-Positron-Emission Tomography, pubmed-meshheading:18310543-Prospective Studies, pubmed-meshheading:18310543-Radiology, Interventional, pubmed-meshheading:18310543-Radiopharmaceuticals, pubmed-meshheading:18310543-Tomography, X-Ray Computed, pubmed-meshheading:18310543-Tumor Markers, Biological
pubmed:year
2008
pubmed:articleTitle
Investigation of FDG-PET/CT imaging to guide biopsies in the detection of histological transformation of indolent lymphoma.
pubmed:publicationType
Letter, Clinical Trial